Brokerage Firm Rating on Rite Aid Corporation (RAD)

Rite Aid Corporation (RAD) : Zacks Investment Research ranks Rite Aid Corporation (RAD) as 4, which is a Sell recommendation. 1 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 4 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 5 research analysts is 2.6, which indicates as a Hold.

Rite Aid Corporation (RAD) : The most positive equity analysts on Rite Aid Corporation (RAD) expects the shares to touch $10, whereas, the least positive believes that the stock will trade at $9 in the short term. The company is covered by 5 Wall Street Brokerage Firms. The average price target for shares are $9.2 with an expected fluctuation of $0.45 from the mean.


Company shares have received an average consensus rating of Hold for the current week Rite Aid Corporation (NYSE:RAD): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $7.50 and $7.45 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $7.61. The buying momentum continued till the end and the stock did not give up its gains. It closed at $7.56, notching a gain of 1.07% for the day. The total traded volume was 21,335,109 . The stock had closed at $7.48 on the previous day.

In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (SVP) of Rite Aid Corp, Donley Douglas E had sold 34,106 shares worth of $265,345 in a transaction dated June 15, 2016. In this transaction, 34,106 shares were sold at $7.78 per share.

Rite Aid Corporation is a retail drugstore chain. The Company sells prescription drugs and a range of other merchandise, which are referred to as front-end products. The Companys drugstores primary business is pharmacy services. It operates approximately 4,570 stores in 31 states across the country and in the District of Columbia. Its front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and various other every day and convenience products. The Company offers a range of products through its portfolio of private brands. Its classes of products include prescription drugs, over-the-counter medications and personal care, health and beauty aids, and general merchandise and other. It sells private brand and co-branded products. It operates under The Rite Aid name.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.